Skip to content Skip to footer
Fluoroestradiol F 18: Benefits, Reviews, Info, Side Effects!
Rx Details
Fluoroestradiol F 18
Fluoroestradiol-18F, FES-18F, 18F-FES
Fluoroestradiol F 18
Prescription
Radiopharmaceutical
Drugs
Radiopharmaceutical
improved breast cancer detection, enhanced imaging of estrogen receptor-positive tumors, non-invasive diagnostic tool, aids in treatment planning, helps monitor therapy response
Allergic Reactions, Changes In Blood Pressure, Dizziness, Flushing, Headache, Injection Site Pain, Nausea
Fluoroestradiol F 18 is a radiopharmaceutical used in positron emission tomography (PET) imaging, particularly for detecting estrogen receptor-positive breast cancer. The dosage of Fluoroestradiol F 18 is typically measured in millicuries (mCi) rather than milligrams or grams, as it is a radioactive tracer. The average dosage for Fluoroestradiol F 18 PET imaging is usually in the range of 1 to 5 mCi, depending on the specific protocol and the equipment used. However, the exact dosage should always be determined by a qualified healthcare professional based on the specific needs of the patient and the imaging equipment.
Breast cancer, estrogen receptor-positive breast cancer
Fluoroestradiol F 18 has a favorable safety profile.
No Interactions Reported
$1,000 – $1,500
$1,500

A Synopsis of

Fluoroestradiol F 18

Fluoroestradiol F 18 is a radiopharmaceutical agent used in positron emission tomography (PET) imaging to detect estrogen receptor-positive tumors in patients with breast cancer. This drug works by binding to estrogen receptors on cancer cells, allowing for the visualization and localization of these tumors.

Fluoroestradiol F 18 is a valuable tool in the management of breast cancer, as it provides important information about the presence and extent of estrogen receptor-positive tumors. This information can help guide treatment decisions, monitor response to therapy, and assess disease progression.

As with any medication, there are potential risks and side effects associated with Fluoroestradiol F 18. These may include allergic reactions, injection site reactions, and rare instances of radiation exposure. It is important for patients to discuss any concerns or questions with their healthcare provider before undergoing a PET scan with this drug.

Overall, Fluoroestradiol F 18 is a safe and effective imaging agent that plays a crucial role in the diagnosis and management of breast cancer. By providing detailed information about estrogen receptor-positive tumors, this drug helps healthcare providers tailor treatment plans to individual patients, ultimately improving outcomes and quality of life.

If you have any questions about Fluoroestradiol F 18 or its use in breast cancer imaging, please do not hesitate to speak with your healthcare provider. They can provide you with more information and address any concerns you may have.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN